SCHEMBL25521674

SCHEMBL25521674

CC(C)c1c(O)cc(-c2nccc3cccnc23)cc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 1/20 0.46
▸ MMP2 P08253 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ CHRM1 P11229 1/20 0.45
▸ COMT P21964 1/20 0.45
▸ ADRA1A P35348 1/20 0.45
▸ METAP2 P50579 1/20 0.45
▸ METAP1 P53582 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ KDM4E B2RXH2 9/20 0.43
▸ L3MBTL1 Q9Y468 6/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ ALOX12 P18054 1/20 0.40
▸ TP53 P04637 4/20 0.39
▸ MAPT P10636 4/20 0.39
▸ CCR1 P32246 3/20 0.39
▸ CCR5 P51681 3/20 0.39
▸ CCR8 P51685 3/20 0.39
▸ HSP90AA1 P07900 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25524101 0.82 MMP2 (0.45) PDE4DMMP2TSHRCHRM1COMT
SCHEMBL25523414 0.77 KDM4E (0.51) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL25523475 0.77 KDM4E (0.44) PDE4DMMP2TSHRCHRM1COMT
SCHEMBL25521549 0.75 DYRK1A (0.50) KDM4EL3MBTL1RAB9ANPC1MAPT
SCHEMBL21686474 0.74 MMP2 (0.53) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL25522331 0.73 L3MBTL1 (0.50) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL3138185 0.72 PDE4D (0.56) PDE4DMMP2TSHRCHRM1COMT
SCHEMBL23853924 0.70 PDE4D (0.58) PDE4DMMP2TSHRCHRM1COMT
SCHEMBL30365932 0.70 NPC1 (0.50) KDM4ERAB9ANPC1TDP1AHR
SCHEMBL24204595 0.70 NPC1 (0.50) KDM4ERAB9ANPC1TDP1AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 — — WO disclosed
Send feedback